B cell costimulatory molecules as potential biomarkers in HAM/TSP

B cell costimulatory molecules as potential biomarkers in HAM/TSP

Bibliographic Details
Main Authors:	Vandamme Anne-Mieke, Khouri Ricardo, Decanine Daniele, Menezes Soraya M, Galvão-Castro Bernardo, Van Weyenbergh Johan
Format:	Article
Language:	English
Published:	BMC 2011-06-01
Series:	Retrovirology

Similar Items

Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo
by: Castro Bernardo, et al.
Published: (2011-06-01)

Difficulties in HAM/TSP diagnosis
by: Carla Maria Sena Andrade Slater, et al.
Published: (2012-09-01)

Considerations on HAM/TSP: rediscovering Tumaco
by: Noboru Yasuda
Published: (1993-03-01)

Recent epidemiologic trends of HAM/TSP in Japan
by: Kubota Ryuji, et al.
Published: (2011-06-01)

A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients
by: Ricardo Khouri, et al.
Published: (2018-05-01)

Genetic diversity in HTLV-1 envelope (gp46), HBZ And LTR region from assymptomatic And TSP/HAM individuals
by: Barreto Fernanda, et al.
Published: (2011-06-01)

Lymphocyte alveolitis in HAM/TSP patients: preliminary report
by: K. Mattos, et al.
Published: (1993-03-01)

Implications of HAM/TSP functional incapacity in the quality of life
by: Marcia Shublaq, et al.
Published: (2011-04-01)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
by: Yoshimi Enose‐Akahata, et al.
Published: (2021-10-01)

Identification of miRnas with possible prognostic roles for HAM/TSP
by: Daniela Raguer Valadão de Souza, et al.
Published: (2023-12-01)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
by: Yoshimi Enose-Akahata, et al.
Published: (2017-12-01)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
by: Mineki Saito
Published: (2019-05-01)

The interaction properties of costimulatory molecules revisited.
by: Collins, A, et al.
Published: (2002)

Neuroimmune semaphorins as costimulatory molecules and beyond
by: Svetlana P. Chapoval
Published: (2018-04-01)

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
by: Gabriel Andrade Nonato Queiroz, et al.
Published: (2019-05-01)

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
by: Taylor Graham P, et al.
Published: (2011-06-01)

Clinical subtype of HAM/TSP based on clinical course and laboratory findings
by: Izumo Shuji, et al.
Published: (2011-06-01)

Gene expression and glycan profiling of CD4+T cells in HAM/TSP
by: Izumo Shuji, et al.
Published: (2011-06-01)

Use of Western blot test for analysis of cerebrospinal fluid in HAM/TSP
by: Luiz Claudio Pereira Ribeiro
Published: (2010-02-01)

The impact of urinary incontinence on the quality of life and on the sexuality of patients with HAM/TSP
by: Maria Rita Polo Gascón, et al.
Published: (2018-07-01)

The impact of urinary incontinence on the quality of life and on the sexuality of patients with HAM/TSP
by: Maria Rita Polo Gascón, et al.

Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development
by: Nicole Lardini Freitas, et al.
Published: (2022-09-01)

Expression of costimulatory molecules in the bovine corpus luteum
by: Pate Joy L, et al.
Published: (2007-01-01)

Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines
by: Moens Britta, et al.
Published: (2012-08-01)

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
by: Tatsufumi Nakamura
Published: (2023-03-01)

Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP
by: Bárbara Brasil Santana, et al.
Published: (2021-02-01)

Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
by: Carvalho Edgar, et al.
Published: (2011-06-01)

Contributions of Costimulatory Molecule CD137 in Endothelial Cells
by: Wei Yuan, et al.
Published: (2021-06-01)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
by: Wels W, et al.
Published: (2004-07-01)

The role of costimulatory molecules in glioma biology and immune microenvironment
by: Ji Wang, et al.
Published: (2022-11-01)

Fcμ receptor as a Costimulatory Molecule for T Cells
by: Andreas Meryk, et al.
Published: (2019-03-01)

Association between Brain White Matter Lesions and Disease Activity in HAM/TSP Patients
by: Keiko Tamaki, et al.
Published: (2024-01-01)

Immunoprofiling of fresh HAM/TSP blood samples shows altered innate cell responsiveness.
by: Brenda Rocamonde, et al.
Published: (2021-11-01)

Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province
by: Amir Reza Tafreshian, et al.
Published: (2014-10-01)

Brain white matter lesions in HAM/TSP: do they have any special meaning?
by: Otávio Augusto Moreno-Carvalho
Published: (2012-04-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Yoshimi Enose-Akahata, et al.
Published: (2019-11-01)

Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Abelardo Q-C Araújo, et al.
Published: (1993-09-01)

DEVELOPMENT OF A SYSTEM OF EXPRESSION CLONING FOR MOLECULES COSTIMULATORY FOR T-CELLS
by: Murray, N, et al.
Published: (1994)

Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!
by: Nargis Khan, et al.
Published: (2012-01-01)

Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells
by: Mario eHubo, et al.
Published: (2013-04-01)